A muted June quarter performance on the back of pricing pressures coupled with worries on regulatory action could hamper the near-term outlook for diagnostic companies. The largest listed diagnostic players, Dr Lal Pathlabs and Thyrocare Technologies have indicated that competitive intensity in the sector is high.

Given the focus on higher volumes, some of the pressures on pricing could continue to hamper the profitability of the companies. Disappointing June quarter This was reflected in the June quarter performance both on volumes and margins. Thyrocare, for example, reported …

.bs-title{width:195px;padding-right:5px;font-size:11px;font-weight:700;color:#000;line-height:20px;vertical-align:middle;display:inline-block;font-family:‘Open Sans‘,sans-serif}.container-data-resize .top .right .text01{font-size:14px;color:#303030;font-weight:700;padding:0 0 10px 0;width:100%;margin-bottom:0;font-family:‘Open Sans‘,sans-serif;line-height:20px;text-align:center}

TO READ THE FULL STORY, NOW AT JUST Rs

Key stories on business-standard are available to premium subscribers only.

Already a premium subscriber?

Pay Using International Credit Card (Issued by bank outside India)

Note: Subscription will be auto renewed, you may cancel any time in the future without any questions asked.

Total Amount Rs. 149.00 Requires personal information

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

What you get?

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all the content on any device through browser or app.
  • Exclusive content, features, opinions and comment – hand-picked by our editors, just for you.
  • Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.
  • 18 years of archival data.
  • Requires you to share personal information like date of birth, income, location amongst other fields. This information alongwith your information will be shared with the partners associated with this program, who contribute towards subsidizing the offer. By subscribing to this product you acknowledge and accept that our Partners may choose to you with offers of their products and services.
  • This is an optional offer – Not comfortable with sharing personal data – please opt for the full price offer which requires you to share minimal information

NOTE :

  • The product is a monthly auto renewal product.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the email with the cancellation request to . Include your number for speedy action. Requests mailed to any other ID will not be acknowledged or actioned upon.

.related-keyword li{float:none!important}

Just-released report names Cannabis Stock of the Year for 2019! Their last pick has seen a +1,200% return since he released it!

This stock has all of the makings of the next great cannabis stock – early-mover advantage, international exposure and influential partnerships, plus it has a product that is unlike anything else on the market…

You will also receive a free, weekly newsletter to stay on top of the latest industry trends, read analysis on promising cannabis stocks, and more. Click here to receive your Free Report immediately!